Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseases

$388,664R01FY2023DKNIH

Johns Hopkins University, Baltimore MD

Investigators

Dao-Fu Daicontact

Linked publications, trials & patents

Paper 38976132 Paper 37274127 Paper 36938088 Paper 36741056

View original record on NIH RePORTER →

Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseases · GrantIndex